Analysts Set Lemonade, Inc. (NYSE:LMND) Price Target at $30.43

Lemonade, Inc. (NYSE:LMND) has received an average recommendation of “Reduce” from the eight ratings firms that are presently covering the stock, Marketbeat Ratings reports. Three investment analysts have rated the stock with a sell recommendation, four have assigned a hold recommendation and one has given a buy recommendation to the company. The average 1-year price target among analysts that have covered the stock in the last year is $30.43.

A number of research firms have recently weighed in on LMND. JMP Securities upped their price objective on Lemonade from $40.00 to $60.00 and gave the stock a “market outperform” rating in a research report on Friday, November 22nd. BMO Capital Markets upped their price target on Lemonade from $13.00 to $15.00 and gave the stock an “underperform” rating in a report on Thursday, November 21st. Keefe, Bruyette & Woods cut Lemonade from a “market perform” rating to an “underperform” rating and lifted their price objective for the company from $18.00 to $21.00 in a research note on Thursday, November 7th. Jefferies Financial Group cut their target price on shares of Lemonade from $15.00 to $14.00 and set an “underperform” rating on the stock in a research note on Wednesday, October 9th. Finally, Piper Sandler lifted their price target on shares of Lemonade from $25.00 to $44.00 and gave the stock a “neutral” rating in a research note on Thursday, November 21st.

Insiders Place Their Bets

In other Lemonade news, COO Adina Eckstein sold 23,644 shares of the business’s stock in a transaction on Tuesday, November 19th. The shares were sold at an average price of $40.00, for a total value of $945,760.00. Following the transaction, the chief operating officer now directly owns 189,653 shares of the company’s stock, valued at approximately $7,586,120. The trade was a 11.09 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CFO Timothy E. Bixby sold 2,050 shares of the company’s stock in a transaction on Tuesday, September 10th. The stock was sold at an average price of $18.24, for a total transaction of $37,392.00. Following the transaction, the chief financial officer now owns 271,552 shares of the company’s stock, valued at approximately $4,953,108.48. The trade was a 0.75 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 132,892 shares of company stock valued at $5,283,045. 12.50% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in LMND. Axiom Advisory LLC raised its stake in shares of Lemonade by 1.6% during the 3rd quarter. Axiom Advisory LLC now owns 54,400 shares of the company’s stock worth $897,000 after buying an additional 850 shares in the last quarter. Blue Trust Inc. grew its holdings in Lemonade by 220.0% during the third quarter. Blue Trust Inc. now owns 2,733 shares of the company’s stock worth $45,000 after acquiring an additional 1,879 shares during the period. Van ECK Associates Corp raised its position in Lemonade by 12.1% in the second quarter. Van ECK Associates Corp now owns 17,774 shares of the company’s stock worth $293,000 after acquiring an additional 1,915 shares in the last quarter. Tidal Investments LLC lifted its holdings in Lemonade by 4.6% in the third quarter. Tidal Investments LLC now owns 45,631 shares of the company’s stock valued at $752,000 after acquiring an additional 2,017 shares during the period. Finally, Price T Rowe Associates Inc. MD boosted its position in shares of Lemonade by 9.8% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 24,609 shares of the company’s stock worth $404,000 after purchasing an additional 2,196 shares in the last quarter. 80.30% of the stock is owned by hedge funds and other institutional investors.

Lemonade Price Performance

Shares of Lemonade stock opened at $51.81 on Thursday. The stock has a market capitalization of $3.70 billion, a price-to-earnings ratio of -17.04 and a beta of 1.68. The business has a 50-day moving average of $26.18 and a 200 day moving average of $20.67. Lemonade has a 12 month low of $14.03 and a 12 month high of $53.85.

Lemonade (NYSE:LMND) last posted its quarterly earnings data on Wednesday, October 30th. The company reported ($0.95) EPS for the quarter, beating the consensus estimate of ($1.02) by $0.07. Lemonade had a negative net margin of 43.51% and a negative return on equity of 32.85%. The business had revenue of $136.60 million during the quarter, compared to analyst estimates of $129.10 million. During the same quarter last year, the firm posted ($0.88) earnings per share. The business’s revenue for the quarter was up 19.3% compared to the same quarter last year. Equities research analysts anticipate that Lemonade will post -3.05 earnings per share for the current year.

Lemonade Company Profile

Lemonade, Inc provides various insurance products through various channels in the United States, Europe, and the United Kingdom. Its insurance products include stolen or damaged property, and personal liability that protects its customers if they are responsible for an accident or damage to another person or their property.